IBDEI0V5 ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,40909,1,4,0)
 ;;=4^L27.1
 ;;^UTILITY(U,$J,358.3,40909,2)
 ;;=^5009145
 ;;^UTILITY(U,$J,358.3,40910,0)
 ;;=L51.1^^119^1751^39
 ;;^UTILITY(U,$J,358.3,40910,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40910,1,3,0)
 ;;=3^Stevens-Johnson Syndrome
 ;;^UTILITY(U,$J,358.3,40910,1,4,0)
 ;;=4^L51.1
 ;;^UTILITY(U,$J,358.3,40910,2)
 ;;=^336636
 ;;^UTILITY(U,$J,358.3,40911,0)
 ;;=L51.3^^119^1751^40
 ;;^UTILITY(U,$J,358.3,40911,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40911,1,3,0)
 ;;=3^Stevens-Johnson Syndrome-Toxic Epdrml Necrolysis Overlap Syndrome
 ;;^UTILITY(U,$J,358.3,40911,1,4,0)
 ;;=4^L51.3
 ;;^UTILITY(U,$J,358.3,40911,2)
 ;;=^336637
 ;;^UTILITY(U,$J,358.3,40912,0)
 ;;=Z12.83^^119^1751^19
 ;;^UTILITY(U,$J,358.3,40912,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40912,1,3,0)
 ;;=3^Screening for Malig Neop of Skin
 ;;^UTILITY(U,$J,358.3,40912,1,4,0)
 ;;=4^Z12.83
 ;;^UTILITY(U,$J,358.3,40912,2)
 ;;=^5062696
 ;;^UTILITY(U,$J,358.3,40913,0)
 ;;=Z48.817^^119^1751^43
 ;;^UTILITY(U,$J,358.3,40913,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40913,1,3,0)
 ;;=3^Surgical Aftercare Following Skin Surgery
 ;;^UTILITY(U,$J,358.3,40913,1,4,0)
 ;;=4^Z48.817
 ;;^UTILITY(U,$J,358.3,40913,2)
 ;;=^5063054
 ;;^UTILITY(U,$J,358.3,40914,0)
 ;;=L94.0^^119^1751^18
 ;;^UTILITY(U,$J,358.3,40914,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40914,1,3,0)
 ;;=3^Scleroderma,Localized
 ;;^UTILITY(U,$J,358.3,40914,1,4,0)
 ;;=4^L94.0
 ;;^UTILITY(U,$J,358.3,40914,2)
 ;;=^5009470
 ;;^UTILITY(U,$J,358.3,40915,0)
 ;;=D23.9^^119^1751^20
 ;;^UTILITY(U,$J,358.3,40915,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40915,1,3,0)
 ;;=3^Sebaceous Hyperplasia
 ;;^UTILITY(U,$J,358.3,40915,1,4,0)
 ;;=4^D23.9
 ;;^UTILITY(U,$J,358.3,40915,2)
 ;;=^5002076
 ;;^UTILITY(U,$J,358.3,40916,0)
 ;;=L21.9^^119^1751^21
 ;;^UTILITY(U,$J,358.3,40916,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40916,1,3,0)
 ;;=3^Seborrhea,Unspec
 ;;^UTILITY(U,$J,358.3,40916,1,4,0)
 ;;=4^L21.9
 ;;^UTILITY(U,$J,358.3,40916,2)
 ;;=^188703
 ;;^UTILITY(U,$J,358.3,40917,0)
 ;;=L91.8^^119^1751^35
 ;;^UTILITY(U,$J,358.3,40917,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40917,1,3,0)
 ;;=3^Skin Tag
 ;;^UTILITY(U,$J,358.3,40917,1,4,0)
 ;;=4^L91.8
 ;;^UTILITY(U,$J,358.3,40917,2)
 ;;=^5009460
 ;;^UTILITY(U,$J,358.3,40918,0)
 ;;=I83.12^^119^1751^38
 ;;^UTILITY(U,$J,358.3,40918,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40918,1,3,0)
 ;;=3^Stasis Dermatitis.Left Leg
 ;;^UTILITY(U,$J,358.3,40918,1,4,0)
 ;;=4^I83.12
 ;;^UTILITY(U,$J,358.3,40918,2)
 ;;=^5007989
 ;;^UTILITY(U,$J,358.3,40919,0)
 ;;=I83.11^^119^1751^37
 ;;^UTILITY(U,$J,358.3,40919,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40919,1,3,0)
 ;;=3^Stasis Dermatitis,Right Leg
 ;;^UTILITY(U,$J,358.3,40919,1,4,0)
 ;;=4^I83.11
 ;;^UTILITY(U,$J,358.3,40919,2)
 ;;=^5007988
 ;;^UTILITY(U,$J,358.3,40920,0)
 ;;=C84.19^^119^1751^23
 ;;^UTILITY(U,$J,358.3,40920,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40920,1,3,0)
 ;;=3^Sezary Disease,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,40920,1,4,0)
 ;;=4^C84.19
 ;;^UTILITY(U,$J,358.3,40920,2)
 ;;=^5001640
 ;;^UTILITY(U,$J,358.3,40921,0)
 ;;=C84.13^^119^1751^26
 ;;^UTILITY(U,$J,358.3,40921,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40921,1,3,0)
 ;;=3^Sezary Disease,Intra-Abdominal Lymph Nodes
 ;;^UTILITY(U,$J,358.3,40921,1,4,0)
 ;;=4^C84.13
 ;;^UTILITY(U,$J,358.3,40921,2)
 ;;=^5001634
 ;;^UTILITY(U,$J,358.3,40922,0)
 ;;=C84.16^^119^1751^27
 ;;^UTILITY(U,$J,358.3,40922,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40922,1,3,0)
 ;;=3^Sezary Disease,Intrapelvic Lymph Nodes
 ;;^UTILITY(U,$J,358.3,40922,1,4,0)
 ;;=4^C84.16
 ;;^UTILITY(U,$J,358.3,40922,2)
 ;;=^5001637
 ;;^UTILITY(U,$J,358.3,40923,0)
 ;;=C84.12^^119^1751^28
 ;;^UTILITY(U,$J,358.3,40923,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40923,1,3,0)
 ;;=3^Sezary Disease,Intrathoracic Lymph Nodes
 ;;^UTILITY(U,$J,358.3,40923,1,4,0)
 ;;=4^C84.12
 ;;^UTILITY(U,$J,358.3,40923,2)
 ;;=^5001633
 ;;^UTILITY(U,$J,358.3,40924,0)
 ;;=C84.14^^119^1751^22
 ;;^UTILITY(U,$J,358.3,40924,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40924,1,3,0)
 ;;=3^Sezary Disease,Axilla/Upper Limb Lymph Nodes
 ;;^UTILITY(U,$J,358.3,40924,1,4,0)
 ;;=4^C84.14
 ;;^UTILITY(U,$J,358.3,40924,2)
 ;;=^5001635
 ;;^UTILITY(U,$J,358.3,40925,0)
 ;;=C84.11^^119^1751^24
 ;;^UTILITY(U,$J,358.3,40925,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40925,1,3,0)
 ;;=3^Sezary Disease,Head/Face/Neck Lymph Nodes
 ;;^UTILITY(U,$J,358.3,40925,1,4,0)
 ;;=4^C84.11
 ;;^UTILITY(U,$J,358.3,40925,2)
 ;;=^5001632
 ;;^UTILITY(U,$J,358.3,40926,0)
 ;;=C84.15^^119^1751^25
 ;;^UTILITY(U,$J,358.3,40926,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40926,1,3,0)
 ;;=3^Sezary Disease,Inguinal Region/LE Lymph Nodes
 ;;^UTILITY(U,$J,358.3,40926,1,4,0)
 ;;=4^C84.15
 ;;^UTILITY(U,$J,358.3,40926,2)
 ;;=^5001636
 ;;^UTILITY(U,$J,358.3,40927,0)
 ;;=C84.18^^119^1751^29
 ;;^UTILITY(U,$J,358.3,40927,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40927,1,3,0)
 ;;=3^Sezary Disease,Multiple Site Lymph Nodes
 ;;^UTILITY(U,$J,358.3,40927,1,4,0)
 ;;=4^C84.18
 ;;^UTILITY(U,$J,358.3,40927,2)
 ;;=^5001639
 ;;^UTILITY(U,$J,358.3,40928,0)
 ;;=C84.17^^119^1751^30
 ;;^UTILITY(U,$J,358.3,40928,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40928,1,3,0)
 ;;=3^Sezary Disease,Spleen
 ;;^UTILITY(U,$J,358.3,40928,1,4,0)
 ;;=4^C84.17
 ;;^UTILITY(U,$J,358.3,40928,2)
 ;;=^5001638
 ;;^UTILITY(U,$J,358.3,40929,0)
 ;;=C84.10^^119^1751^31
 ;;^UTILITY(U,$J,358.3,40929,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40929,1,3,0)
 ;;=3^Sezary Disease,Unspec Site
 ;;^UTILITY(U,$J,358.3,40929,1,4,0)
 ;;=4^C84.10
 ;;^UTILITY(U,$J,358.3,40929,2)
 ;;=^5001631
 ;;^UTILITY(U,$J,358.3,40930,0)
 ;;=A53.9^^119^1751^44
 ;;^UTILITY(U,$J,358.3,40930,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40930,1,3,0)
 ;;=3^Syphilis,Unspec
 ;;^UTILITY(U,$J,358.3,40930,1,4,0)
 ;;=4^A53.9
 ;;^UTILITY(U,$J,358.3,40930,2)
 ;;=^5000310
 ;;^UTILITY(U,$J,358.3,40931,0)
 ;;=B35.1^^119^1752^9
 ;;^UTILITY(U,$J,358.3,40931,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40931,1,3,0)
 ;;=3^Tinea Unguium
 ;;^UTILITY(U,$J,358.3,40931,1,4,0)
 ;;=4^B35.1
 ;;^UTILITY(U,$J,358.3,40931,2)
 ;;=^119748
 ;;^UTILITY(U,$J,358.3,40932,0)
 ;;=F63.3^^119^1752^12
 ;;^UTILITY(U,$J,358.3,40932,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40932,1,3,0)
 ;;=3^Trichotillomania
 ;;^UTILITY(U,$J,358.3,40932,1,4,0)
 ;;=4^F63.3
 ;;^UTILITY(U,$J,358.3,40932,2)
 ;;=^5003643
 ;;^UTILITY(U,$J,358.3,40933,0)
 ;;=B35.2^^119^1752^6
 ;;^UTILITY(U,$J,358.3,40933,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40933,1,3,0)
 ;;=3^Tinea Manuum
 ;;^UTILITY(U,$J,358.3,40933,1,4,0)
 ;;=4^B35.2
 ;;^UTILITY(U,$J,358.3,40933,2)
 ;;=^5000605
 ;;^UTILITY(U,$J,358.3,40934,0)
 ;;=B35.6^^119^1752^5
 ;;^UTILITY(U,$J,358.3,40934,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40934,1,3,0)
 ;;=3^Tinea Cruris
 ;;^UTILITY(U,$J,358.3,40934,1,4,0)
 ;;=4^B35.6
 ;;^UTILITY(U,$J,358.3,40934,2)
 ;;=^119711
 ;;^UTILITY(U,$J,358.3,40935,0)
 ;;=B35.3^^119^1752^8
 ;;^UTILITY(U,$J,358.3,40935,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40935,1,3,0)
 ;;=3^Tinea Pedis
 ;;^UTILITY(U,$J,358.3,40935,1,4,0)
 ;;=4^B35.3
 ;;^UTILITY(U,$J,358.3,40935,2)
 ;;=^119732
 ;;^UTILITY(U,$J,358.3,40936,0)
 ;;=B35.4^^119^1752^4
 ;;^UTILITY(U,$J,358.3,40936,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40936,1,3,0)
 ;;=3^Tinea Corporis
 ;;^UTILITY(U,$J,358.3,40936,1,4,0)
 ;;=4^B35.4
 ;;^UTILITY(U,$J,358.3,40936,2)
 ;;=^119704
 ;;^UTILITY(U,$J,358.3,40937,0)
 ;;=L51.2^^119^1752^11
 ;;^UTILITY(U,$J,358.3,40937,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40937,1,3,0)
 ;;=3^Toxic Epidermal Necrolysis
 ;;^UTILITY(U,$J,358.3,40937,1,4,0)
 ;;=4^L51.2
 ;;^UTILITY(U,$J,358.3,40937,2)
 ;;=^5009206
 ;;^UTILITY(U,$J,358.3,40938,0)
 ;;=B35.0^^119^1752^2
 ;;^UTILITY(U,$J,358.3,40938,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40938,1,3,0)
 ;;=3^Tinea Barae/Capitis
 ;;^UTILITY(U,$J,358.3,40938,1,4,0)
 ;;=4^B35.0
 ;;^UTILITY(U,$J,358.3,40938,2)
 ;;=^5000604
 ;;^UTILITY(U,$J,358.3,40939,0)
 ;;=B36.3^^119^1752^3
 ;;^UTILITY(U,$J,358.3,40939,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40939,1,3,0)
 ;;=3^Tinea Blanca
 ;;^UTILITY(U,$J,358.3,40939,1,4,0)
 ;;=4^B36.3
 ;;^UTILITY(U,$J,358.3,40939,2)
 ;;=^266864
 ;;^UTILITY(U,$J,358.3,40940,0)
 ;;=B36.1^^119^1752^7
 ;;^UTILITY(U,$J,358.3,40940,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40940,1,3,0)
 ;;=3^Tinea Nigra
 ;;^UTILITY(U,$J,358.3,40940,1,4,0)
 ;;=4^B36.1
 ;;^UTILITY(U,$J,358.3,40940,2)
 ;;=^264999
 ;;^UTILITY(U,$J,358.3,40941,0)
 ;;=B36.0^^119^1752^10
 ;;^UTILITY(U,$J,358.3,40941,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40941,1,3,0)
 ;;=3^Tinea Veriscolor
 ;;^UTILITY(U,$J,358.3,40941,1,4,0)
 ;;=4^B36.0
 ;;^UTILITY(U,$J,358.3,40941,2)
 ;;=^5000608
 ;;^UTILITY(U,$J,358.3,40942,0)
 ;;=L81.8^^119^1752^1
 ;;^UTILITY(U,$J,358.3,40942,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40942,1,3,0)
 ;;=3^Tattoo Pigmentation
 ;;^UTILITY(U,$J,358.3,40942,1,4,0)
 ;;=4^L81.8
 ;;^UTILITY(U,$J,358.3,40942,2)
 ;;=^5009318
 ;;^UTILITY(U,$J,358.3,40943,0)
 ;;=L80.^^119^1753^12
 ;;^UTILITY(U,$J,358.3,40943,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40943,1,3,0)
 ;;=3^Vitiligo
 ;;^UTILITY(U,$J,358.3,40943,1,4,0)
 ;;=4^L80.
 ;;^UTILITY(U,$J,358.3,40943,2)
 ;;=^127071
 ;;^UTILITY(U,$J,358.3,40944,0)
 ;;=I83.019^^119^1753^7
 ;;^UTILITY(U,$J,358.3,40944,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40944,1,3,0)
 ;;=3^Varicose Veins Right Lower Extrem w/ Ulcer Site Unspec
 ;;^UTILITY(U,$J,358.3,40944,1,4,0)
 ;;=4^I83.019
 ;;^UTILITY(U,$J,358.3,40944,2)
 ;;=^5007979
 ;;^UTILITY(U,$J,358.3,40945,0)
 ;;=I83.029^^119^1753^2
 ;;^UTILITY(U,$J,358.3,40945,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40945,1,3,0)
 ;;=3^Varicose Veins Left Lower Extrem w/ Ulcer Site Unspec
 ;;^UTILITY(U,$J,358.3,40945,1,4,0)
 ;;=4^I83.029
 ;;^UTILITY(U,$J,358.3,40945,2)
 ;;=^5007986
